[ Price : $8.95]
FDA grants Daiichi Sankyo accelerated approval for Enhertu for treating adult patients with unresectable or metastatic non-small c...[ Price : $8.95]
Attorney Sara Koblitz says an Avadel suit against FDA challenges the agency's authority to list some patents in the Orange Book an...[ Price : $8.95]
FDA says its clinical hold on a MaaT Pharma Phase 3 trial of an investigational graft-versus-host disease drug remains in place wh...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled "Mammography Quality Standards Act Req...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection revision entitled: "Environmental Impact Considerations."[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled "Medical Device Accessories."[ Price : $8.95]
FDA says the Becton Dickinson recall of three intraosseous medical devices is Class 1.[ Price : $8.95]
The Menarini Group, supported by Radius Health, submits an NDA to FDA for elacestrant to treat some breast cancers.